Ralf S. Mueller

Evaluation of Two Induction Protocols for Oclacitinib in Dogs

ABSTRACT Background Oclacitinib is approved for the treatment of canine atopic dermatitis (AD) and pruritus. The conventional administration protocol includes twice‐daily oral dosing for 14 days with a subsequent reduction to once‐daily administration. This reduction sometimes le...